0 results found in this keyword

China allows limited use of COVID-19 vaccine


  •   2 min reads
China allows limited use of COVID-19 vaccine

The vaccine has been approved for a period of one year after clinical trials proved it was safe and showed some efficacy.China’s military has received the green light to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials proved it was safe and showed some efficacy, the company said on Monday.The Ad5-nCoV is one of China’s eight vaccine candidates approved for human trials at home and abroad for the respiratory disease caused by the new coronavirus. The shot also won approval for human testing in Canada.

He Ad5-nCoV is one of China’s eight vaccine candidates approved for human trials at home and abroad for the respiratory disease caused by the new coronavirus. Image credit: CanSino BiologicalsChina’s Central Military Commission approved the use of the vaccine by the military on 25 June for a period of one year, CanSino said in a filing. The vaccine candidate was developed jointly by CanSino and a research institute at the Academy of Military Science (AMS).

Related News

You've successfully subscribed to Newsportal
Great! Next, complete checkout for full access to Newsportal
Welcome back! You've successfully signed in
Success! Your account is fully activated, you now have access to all content.
Success! Your billing info is updated.
Billing info update failed.
Your link has expired.